Earnings call transcript: CVS Group H2 2026 results show growth, shares fall

CVS Group PLC reported H2 2026 results showing a 5.9% rise in full-year revenue to GBP 712.8 million, with adjusted earnings per share increasing 6.9% to 85.6 pence. The company's adjusted EBITDA grew 5.1% to GBP 141.5 million, but like-for-like revenue growth slowed to 2.1%. Despite the decline, the stock fell 5.07% to $1236, below its 52-week high.

The company's performance was impacted by extreme weather, softer U.K. consumer confidence, and higher employment costs, but analysts suggest the stock is currently undervalued.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.